Inactive

Short Title: This is a Sources Sought notice for DP Manufacturing with vial fills in the range of 20,000 to 60,000 vials supporting DynPort's Recombinant Botulinum Vaccine A/B (rBV A/B) Program. RFI/R... Short Title: This is a Sources Sought notice for DP Manufacturing with vial fills in the range of 20,000 to 60,000 vials supporting DynPort's Recombinant Botulinum Vaccine A/B (rBV A/B) Program. RFI/RFP No: DVC0659-BOT-19 Response Date: Must respond by October 14, 2019 Synopsis: Classification Code: A - Research & Development NAICS Code: 541 - Professional Scientific and Technical Services/541711 - Research & Development in Biotechnology Description: This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts or quotations. The objective of this notice is to identify businesses in the area of Drug Product (DP) manufacturing. Responding parties must be able to demonstrate expertise and capabilities in the following areas: Drug Product Manufacturing at a scale of 20,000 to 60,000 vials in a cGMP environment. ITAR Compliance - Ability to comply with the requirements for ITAR Contact Information: DVC requests that you provide a response directly to Alesha Subasic at alesha.subasic@gdit.com indicating if you have or do not have the expertise, capabilities and interest in pursuing further discussions. Should DVC elect to pursue discussions, a Non-Disclosure Agreement will be executed. Should you have interest, please include in your response the following Business information in your email: a. DUNS number b. Company Name c. Company Address d. Company Points of Contact (both technical and administrative/business), including names, titles, addresses, telephone and fax numbers and email addresses. e. Type of Company (i.e. small business, 8(a), woman owned, veteran owned, etc). Disclaimer: This notice does not obligate DVC to award a contract or otherwise pay for the information provided in response. Note that DVC will not entertain questions regarding this Market Research; however, general questions can be presented in your response. Confidentiality: No proprietary, classified, confidential or sensitive information should be included in your response.